Big Gain For Predictive Oncology Inc.
Predictive Oncology Inc. (POAI:NASDAQ) rocketted at $1.87, a gain of 74.8%. On Thu, Jul 25, 2024, POAI:NASDAQ hit a New 2-Week High of $1.87. The stock got featured on our News Catalysts scanner on Thu, Jul 25, 2024 at 08:03 AM in the 'BIOTECH' category. From Thu, Jul 11, 2024, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Thu, Jul 25, 2024 at $2.99 with a volume of 160M+.
About Predictive Oncology Inc. (POAI:NASDAQ)
Precision Therapeutics Inc functions in the healthcare domain. It is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Company distributes these products to hospitals, surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented and disposed of.
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 150%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 100%
- The Container Store Group, Inc. (TCS:NYSE), 85.87%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- Predictive Oncology Inc. (POAI:NASDAQ), 74.77%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 63.55%
- Nvni Group Limited (NVNI:NASDAQ), 56.2%
- Arrowroot Acquisition Corp. (ARRW:NASDAQ), 54.64%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 54.48%